MoneyWorks4Me

Medico Remedies informs about investor presentation

11 Jan 2024 Evaluate

Pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Medico Remedies has informed that it enclosed Investor Presentation for Q2 FY 2023-24 of the Company.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1864.00
Dr. Reddys Labs. 1140.80
Cipla 1380.00
Lupin 2075.00
Zydus Lifesciences 1118.00
View more..